Table 2 Summary of reporting guidelines endorsement in Chinese medical journals
| Â | Endorsement type | Â | |||
|---|---|---|---|---|---|
Reporting Guideline (n = 1039*) | Active strong n (%) | Active weak n (%) | Passive moderate n (%) | Passive weak n (%) | None n (%) |
CONSORT | 108 (10.4) | 49 (4.7) | 64 (6.2) | 29 (2.8) | 789 (75.9) |
CONSORT Extension | 8 (0.8) | 0 (0) | 0 (0) | 0 (0) | 1031 (99.2) |
STROBE | 152 (14.6) | 21 (2.0) | 6 (0.6) | 0 (0) | 860 (82.8) |
PRISMA | 151 (14.5) | 20 (1.9) | 1 (0.1) | 0 (0) | 867 (83.4) |
SPIRIT | 2 (0.2) | 5 (0.5) | 0 (0) | 0 (0) | 1032 (99.3) |
STARD | 148 (14.2) | 16 (1.5) | 6 (0.6) | 0 (0) | 869 (83.6) |
TRIPOD | 2 (0.2) | 3 (0.3) | 0 (0) | 0 (0) | 1034 (99.5) |
CARE | 145 (14.0) | 8 (0.8) | 1 (0.1) | 0 (0) | 885 (85.2) |
AGREE | 2 (0.2) | 3 (0.3) | 1 (0.1) | 0 (0) | 1033 (99.4) |
RIGHT | 3 (0.3) | 3 (0.3) | 0 (0) | 0 (0) | 1033 (99.4) |